Trial Profile
Phase I-II Study of Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia (CLL) Patients.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Valproic acid (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 07 Aug 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jun 2012)
- 19 Feb 2011 New trial record